Steve Pakola, an officer serving as Chief Medical Officer, reported sales under a Rule 10b5-1 trading plan. The transactions were sales of common stock executed on 2026-06-29 and 2026-07-01 at a weighted average price of $12.22 per share (weighted across multiple trades; one sale reported at a weighted $11.04 reflecting trades from $11.00–$11.18). The total proceeds from the two sales reported were $688,755. After the reported transactions, Pakola directly owned 213,009 shares of common stock. The reporting person noted that the disposed shares were sold directly and that the earlier option referenced vests 25% on January 2, 2026, with the remainder vesting monthly over the following 36 months while providing continuous service.
| Reporter NamePakola Steve | RelationshipChief Medical Officer | TypeSell | Amount$688,755 | SEC Filing |